Patents by Inventor Michael Tennant

Michael Tennant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060239972
    Abstract: Adiponectin cDNA was cloned into AAV serotypes 1, 2, and 5-based expression vectors. Virions containing these vectors were administered to the livers of rat subjects via portal vein injection. A single injection of 6×1011 virions of the vector caused a sustained and statistically significant reduction in body weight of the treated animals compared to the control animals. This occurred in the absence of side effects. Compared to control animals, the subject rats also exhibited reduced adipose tissue mass, reduced appetite, improved insulin sensitivity, and improved glucose tolerance.
    Type: Application
    Filed: November 22, 2005
    Publication date: October 26, 2006
    Inventors: Sergei Zolotukhin, Michael Tennant
  • Publication number: 20050153966
    Abstract: The invention relates to compounds of the following formula that may be used to inhibits kinases, as well as compositions of matter and kits comprising these compounds. The present invention also relates to methods for inhibiting kinases, as well as treatment methods using compounds according to the present invention.
    Type: Application
    Filed: December 17, 2004
    Publication date: July 14, 2005
    Inventors: Anthony Gangloff, Jacek Nowakowski, Bheema Paraselli, Jeffrey Stafford, Michael Tennant